Introduction
Retinoids are a group of vitamin A-related compounds exhibiting various regulatory functions such as inhibition of proliferation and induction of differentiation. A prototype of these is the all-trans-retinoic acid (RA), a natural metabolite. RA binds to a heterodimer of two classes of nuclear retinoic acid receptors (RAR/ RXR), which associate with RA response elements (RARE) to stimulate target gene expression (Chambon, 1996; Mangelsdorf et al., 1995) . Three isomers, 13-cis-RA, all-trans-RA and 9-cis-RA, have been identi®ed as ligands for RAR/RXR, whereas homodimerized RXRs bind to the 9-cis isomer with high anity (Alleby et al., 1993) .
RA is a strong cyto-dierentiating agent ecient in the clinical treatment of acute promyelocytic leukaemia (APL), the M3 subtype in the French-American-British (FAB) classi®cation (Warrell et al., 1993; Castaigne et al., 1990) . APL is characterized by a developmental arrest of granulopoiesis at the promyelocytic stage. This pathology is associated with the t(15;17) translocation that causes the fusion of a gene called PML (ProMyelocytic Leukaemia) with the RARa locus and expression of a PML-RARa chimeric protein in leukaemic cells under the control of the PML promoter (de TheÂ et al., 1991; Kakizuka et al., 1991; Pandol® et al., 1991) . Expression of the chimeric protein causes delocalization of PML and other components from nuclear bodies (NBs) to a microspeckled nuclear structure. Dierentiation of APL with RA results in restoration of their normal localization on NBs as well as degradation of the chimeric protein (Koken et al., 1994; Weis et al., 1994; Yoshida et al., 1996) . One of the main problems in APL treatment is the appearance of retinoid resistance (Kizaki et al., 1997) . Ex vivo, on resistant cells, RA alone is unable to induce maturation and to inhibit cell growth (Duprez et al., 1992) . The molecular mechanisms responsible for RA insensitivity are still unclear.
Interferons (IFNs), classi®ed as a, b, or g on the basis of their antigenic properties, are a group of multifunctional cytokines that regulate cellular antiviral, anti-tumour and immunological responses (Pestka et al., 1987; Pfeer et al., 1998; Sen and Ransoho, 1993) through IFN-stimulated genes (ISG) expression. IFNs a and b (type I) are produced by many types of cells in response to viral infection, double stranded RNA treatment or other stimuli (De Maeyer and De Maeyer-Guignard, 1988) . IFNg (type II) is induced in T-lymphocytes and natural killer cells in response to antigens or mitogens. Type I and II IFNs, following binding to dierent speci®c cell surface receptors, induce transcription of ISG through activation of Janus-type tyrosine kinases resulting in tyrosine phosphorylation of the Signal Transducers and Activators of Transcription (STAT) proteins (Pelligrini and Dusanter-Fourt, 1997; Pellegrini and Schindler, 1993; Schindler and Darnell, 1995) . In response to IFNa/b, Jak1 and Tyk2 phosphorylate Stat1, Stat2 and Stat3. The IFN-Stimulated Gene Factor 3 (ISGF3) is formed by Stat1 and Stat2 (Stat1 : 2) in association with the DNA-binding protein, p48, a member of the Interferon Regulatory Factor (IRF) family Schindler et al., 1992) . This complex binds to the IFN-Stimulated Response Element (ISRE) found in promoters of IFNa/b-stimulated genes. In addition, homo-and heterodimers of Stat1 and Stat3 (Stat1 : 1, Stat3 : 3 and Stat1 : 3) bind to a palindromic version of the IFNg-activated site (GAS), regulating the expression of distinct ISG (Kanno et al., 1993; Khan et al., 1993; Pine et al., 1994) . In response to IFNg, Jak1 and Jak2 phosphorylate Stat1 which forms homodimers which bind to the GAS motif. Characterization of these signaling pathways has provided some insights into the overlapping or synergistic eects of various IFNs.
IFNs and RA are known inhibitors of cell proliferation and they have been used in the treatment of certain forms of malignancy Eisenhauer et al., 1994; Pfeer et al., 1998) . In vitro and in vivo, their combination leads to a more potent growth inhibition (Giandomenico et al., 1997; Handa et al., 1997; Kumar and Korutla, 1995; Lancillotti et al., 1995; Pelicano et al., 1997) . Dierent studies have recently shown that RA directly increases the expression of three transcription factors playing a central role in the mechanisms of IFN action. RA increases the level of both STAT (Stat1 and Stat2) and IRF (IRF-1 and p48) gene expression (Gianni et al., 1997; Kolla et al., 1996; Matikainen et al., 1996 Matikainen et al., , 1997 Pelicano and Chelbi-Alix, 1998; Pelicano et al., 1997) . Additional mechanisms could be involved as RA also causes the induction and secretion of IFN (Pelicano et al., 1997) . As a consequence of these events, RA enhances the IFN-induced STAT activation. Thus, the capacity of RA to increase the expression of STAT and IRF proteins and to induce IFN synthesis may be a crucial step in the enhancement of biological responses to IFN.
The NB4 cell line (Lanotte et al., 1991 ) is characterized by a promyelocytic morphology, sensitivity to the dierentiating, antiproliferative and proapoptotic actions of RA. Two distinct types of maturation de®cient NB4 cell sublines, NB4-R1 and NB4-R2, were isolated from the RA-sensitive parental line (Ruchaud et al., 1994) . It has been shown that the basal level of RARa, RXRa and PML mRNAs and proteins were roughly the same in the three cell lines (Duprez et al., 1996a) . While NB4, NB4-R1 and NB4-R2 cells express comparable amounts of PML-RARa mRNA, only NB4 and NB4-R1 cells express the chimeric protein. In NB4-R1 cells, RA-induced PMLRARa decrease is associated with changes in surface markers but not terminal maturation (Duprez et al., 1996a) . As suggested previously (Gianni et al., 1998) , in RA-resistant cells, induction of PML-RARa degradation may be a ®rst step but is not sucient for the full response to RA. The expression of the chimeric protein is upregulated by IFNs Nason-Burchenal et al., 1995) , this because PML is a primary target gene of both type I and II IFNs and the expression of PMLRARa in APL cells is under the control of the PML promoter.
NB4-R1 cells treated with low doses of RA fail to mature, although they respond to RA since they can be subsequently triggered maturation by an additional cAMP signal (cAMP is inactive given alone) (Duprez et al., 1996b) . NB4-R2 cells were resistant to the combined RA and cAMP treatment. In the parental NB4 cells, RA and cAMP act synergistically to induce maturation (Duprez et al., 1996b) .
This allowed us to study the capacity of RA to induce IFN synthesis and the expression of the transcription factors Stat1, p48 and IRF-1 in relation to growth inhibition and maturation of APL cells. RA resistant cells could help understand mechanisms by which RA induces IFN synthesis. This prompted us to investigate: (1) the nature of RA-induced IFN in NB4 cells, (2) whether RA induces IFN synthesis in the resistant cells, (3) if the expression of Stat1, p48 and IRF-1 are altered in the resistant cells, (4) the role of RA-induced IFN in the growth and dierentiation of NB4 cells.
Results
RA and IFN act cooperatively to inhibit cell growth and induce dierentiation in NB4 but not in RA-resistant cells
In dierent cell lines, IFNs and RA act cooperatively to induce dierentiation, inhibition of cell and viral growth. It was important to determine if such eects were also observed in RA-resistant cells. NB4, NB4-R1 and NB4-R2 cells were treated for 3 days with 1000 units of IFNa, 1 mM RA or their combination. Viable cells were counted and expressed in percentage relative to the untreated control cultures (Figure 1a) . RA alone exerted an antiproliferative eect in NB4 cells with an inhibition of 30% at day 3, but did not alter cell growth in NB4-R1 and NB4-R2 as previously reported by Lanotte group (Duprez et al., 1992) . IFNa altered in a similar manner the growth of the three cell lines with an inhibition of about 35% at day 3, suggesting that the IFN receptors are functional. When these cells were treated with a combination of IFNa and RA, an enhanced antiproliferative eect (58%) was observed in NB4 but not in NB4-R1 and NB4-R2 cells (Figure 1a) . In NB4 but not in NB4-R1 and NB4-R2 cells, treatment with RA-IFNa (1 mM and 100 units/ml respectively) combination aorded more antiviral protection against VSV infection than that with IFNa alone (100 units/ml) (data not shown). As maturation is associated with the ability of myeloid cells to produce superoxide, NB4 and the resistant cells were examined with the NBT reduction assay before and after the same treatment (Figure 1b) . NB4 cells were responsive to RA but did not respond to IFNa alone. However, with the combination of the two agents, there was an increased maturation eect. In contrast, the resistant cell lines NB4-R1 and NB4-R2 harboured no response to RA, IFNa or their combination.
Taken together, these results show that IFNa treatment induced a partial growth inhibition but did not induce dierentiation in the three cell lines. RAIFNa combination led to higher induced biological activities such as dierentiation, inhibition of cell growth and viral replication in NB4 cells but not in the resistant cells. 
RA induced IFN synthesis in NB4 cells but not in NB4-R1 and NB4-R2 cells
In order to know if RA induces IFN synthesis in NB4 cells and if this capacity is altered in the resistant cells, NB4, NB4-R1 and NB4-R2 cells were treated with 1 mM RA for 5 days. The supernatant, saved daily, was tested by the ability of the culture medium of RAtreated cells to induce antiviral activities in MDBK and F2000 cells in which these activities were highly induced by IFN but not by RA (data not shown). In NB4 cells, RA induced the synthesis and the secretion of IFN with a high titer value of 256 IU/ml between day 4 and 5 as tested on MDBK or F2000 cells ( Figure  2a and data not shown). In contrast, no detectable IFN activity was found in supernatants from RA-treated resistant cells NB4-R1 and NB4-R2 ( Figure 2a ). All untreated cells did not secrete detectable IFN activity. Extracts prepared from unstimulated or RA-stimulated NB4, NB4-R1 and NB4-R2 cells were analysed by the immunoblotting assay for the presence of two ISG products, the RNA-dependent protein kinase (PKR) and the NBs-associated Sp100 protein, an autoantigen of primary biliary cirrhosis. PKR and Sp100 were similarly induced by IFNa in the three cell lines (data not shown). Upon RA treatment for 3 days, PKR and Sp100 were highly induced in NB4 cells and not aected in the two resistant cells, con®rming that IFN is only induced in the parental cell line ( Figure 2b ). In order to know which IFN types RA induced, the supernatants from RA-treated NB4 cells were challenged with anti-human IFNa, b or g antibodies (in amounts sucient to neutralize 1000 units/ml). Then, the antiviral activities were tested on F2000 cells. Antihuman IFNb or IFNg antibodies did not alter the antiviral activity of RA-induced IFN on F2000 cells, whereas anti-human IFNa antibodies abolished it totally ( Figure 2c ). This demonstrates that RA induces in NB4, but not in resistant cells, the synthesis and the secretion of IFNa.
Stat1 expression and activation in RA-treated NB4 and resistant cells
Since RA did not amplify IFN-induced biological activities in the resistant cells (Figure 1 ), the fate of Stat1 upon RA treatment for 5 days was studied in these cells. Extracts from unstimulated or RAstimulated NB4, NB4-R1 and NB4-R2 cells were examined by a sensitive Stat1 speci®c immunoblotting assay (Figure 3a) . Basal level of Stat1 can be detected in the three cell lines depending on the exposure time. Kinetics studies indicated that in NB4 cells, RA increased the level of Stat1 slightly at day 1 and with a maximum between days 3 and 5. In contrast, in the resistant cells, RA was totally unable to increase Stat1 and Stat2 expression both in NB4-R1 and NB4-R2, as revealed by Western or Northern blots (Figure 3a and b and data not shown). IFNa and IFNg, used as positive control in these experiments, were able to increase the expression of Stat1 in the three cell lines demonstrating again that these resistant cells are sensitive to both types I and II IFNs.
Contradictory results were found concerning the capacity of RA to stimulate directly the tyrosine phosporylation of Stat1 (Gianni et al., 1997; Matikainen et al., 1996; Pelicano et al., 1997) . To investigate whether RA induces Stat1 phosphorylation during short time treatment, thus increasing the level of DNA-binding complexes containing this protein, nuclear extracts were prepared from NB4 and resistant cells pretreated for 10 min with RA, prior stimulation with IFNa or IFNg and assayed by EMSA with a GAS probe as previously described (Pine et al., 1994) . IFNa and IFNg increased the levels of a nuclear complex capable of interacting with the GAS oligonucleotide in NB4, NB4-R1 and NB4-R2 cells (Figure 4a) . A supershift was obtained in the presence of anti-Stat1 antibodies (data not shown). As shown in Figure 4a , RA alone never led to the activation of Stat1 DNAbinding activity, and pretreatment of NB4 cells with RA for 10 min did not increase the level of the GAS retarded band induced by IFN stimulation (Figure 4a level was increased by IFNa or IFNg used as positive controls. Taken together, these results show that RA is not able to induce directly tyrosine phosphorylation of Stat1. However, as shown previously in MCF-7, HL60 and WISH cells (Kolla et al., 1996; Pelicano et al., 1997) , RA pretreatment of NB4 cells (more than one day) did signi®cantly increase Stat1 activation in response to IFNa or IFNg. In contrast, priming resistant cells for 3 days with RA had no eect in increasing IFN responses in NB4-R1 and NB4-R2 cells; it may even cause a small decrease in Stat1 DNAbinding activity (Figure 4a ). Ten minutes RA pretreatment also reduces Stat1 activity after IFNa in NB4 and NB4-R1 cells. RA dierently modulates IRF-1 and p48 expression in NB4 and resistant cells IRF-1, is a transcription activator that regulates the expression of type I IFN , and IFNinducible genes (Pine et al., 1990) . We have shown that RA stimulates the IRF-1 gene expression with the same eciency as IFNa (Pelicano et al., 1997) . In addition, the GAS motif (Pine et al., 1994) , which mediates the induction of IRF-1 in response to IFNs, seems to be the major or unique RA responsive element in the IRF-1 promoter (Pelicano et al., 1997) . Another member of the IRF family, the p48 protein, is also upregulated by RA (Gianni et al., 1997; Pelicano and Chelbi-Alix, 1998) . We have analysed the fate of IRF-1 and p48 upon RA treatment in NB4 and the resistant cells. Kinetic studies show that in NB4 cells, p48 and IRF-1 expressions were dierently up regulated by RA. p48 increased slightly at day 1 and reached a maximum at day 2 that was maintained until day 5 (Figure 5a ), whereas an important increase was observed for IRF-1 at day 1, with a maximum at day 2 and 3 and a subsequent decline at day 4 ( Figure 5b ). The fate of these two proteins upon RA treatment is also dierent in the resistant cell lines. In NB4-R1 and NB4-R2 cells, the induction of p48 by RA was totally blocked, whereas that of IRF-1 was increased in both NB4-R1 and NB4-R2 cells. In order to verify if these inductions were also observed at the transcriptional level, total RNAs were isolated from NB4, NB4-R1 and NB4-R2 cells treated for 6 h with RA in the absence or the presence of cycloheximide. Cycloheximide alone induced IRF-1 mRNA and had a synergistic eect on IRF-1 expression in the three cell lines when combined with RA ( Figure 5c ). The capacity of RA to increase IRF-1 mRNA level seems to be reduced in both resistant cell lines compared to NB4 cells although the synergistic eect was similar in the three cell lines (Figure 5c ). In the three cell lines, the level of IRF-2 is similar in unstimulated or RA-stimulated cells (data not shown).
RA did not induce neither IRF-3 protein expression nor its phosphorylation
Upon Sendai virus infection, cytoplasmic IRF-3 is phosphorylated and translocated into the nucleus where it is able to bind IFNa and IFNb promoters (Schafer et al., 1998) . In addition IRF-3 expression inhibits IRF-1 mediated transactivation of the murine IFN-a4 gene, suggesting that IRF-3 exerts an IRF-2-like repressive eect by occupying the IRF-1 binding site and thus preventing transactivation by IRF-1 (Schafer et al., 1998) . In order to know whether IRF-3 could be implicated in mechanisms responsible for RA-induced IFN, NB4 cells were treated by RA for long and short periods and their extracts were analysed by Western blot. Extracts from NB4 cells Figure 6 Eect of RA on IRF-3 protein expression and phosphorylation. NB4 cells (1.5610 5 /ml) were treated for long (a) or short (b) period with 1 mM RA or infected with Sendai virus (b). At the indicated times, cells were lysed as described , the dierent extracts from untreated, RA-treated or Sendai virus-infected cells were analysed by Western blot and revealed by anti-IRF-3 or-actin antibodies Figure 7 Role of RA-induced IFN in dierentiation and inhibition of NB4 cell growth. Cells (1.5610 5 /ml) were treated for 3 days with 1 mM RA or 1000 units/ml of IFNa with or without anti-IFNa antibodies (in amounts sucient to neutralize 1000 units of IFN/ml). The antibodies were added each 12 h to cell cultures. At day 3, viable cells were counted and represented relative to the control untreated cells, each value represents the mean of three independent measurements in which standard deviation did not exceed 4% (a) and NBT assay were determined (b) infected with Sendai virus were used as positive control for phosphorylated IRF-3. Treatment of NB4 cells with RA for 5 days did not enhance IRF-3 protein expression; there is even a small decrease at day 4 and 5 ( Figure 6a ). As previously shown in 293 cell line , infection with Sendai virus for 6 or 9 h of NB4 cells resulted in the generation of a more slowly migrating phosphorylated IRF-3 (Figure 6b ). However, this band was not observed in RA-treated NB4 cells suggesting that RA induced neither the expression nor the phosphorylation of IRF-3.
Role of RA-induced IFN in dierentiation and inhibition of NB4 cell growth
In NB4 cells, RA induced the synthesis and the secretion of IFN at day 3 with a titer value between 64 to 96 IU/ml (Figure 2a) . We have studied the eect of RA-induced IFN on RA-induced dierentiation and inhibition of cell growth of NB4 cells. NB4 cells were treated for 3 days with 1 mM RA in the absence or the presence of anti-human IFNa antibodies. Viable cells were counted daily and NBT reduction was determined at day 3. The anti-IFNa antibodies abolished in part RA-induced inhibition of NB4 cell growth (12% inhibition against 37% with RA alone, (Figure 7a ) and altered slightly their dierentiation (Figure 7b ). This suggests that the RA inhibitory eect on cell growth could be due in part to the induction and subsequent secretion of IFNa. IFNa per se did not induce dierentiation in NB4 cells (Figure 1) . However, the growth inhibitory eect of IFN might facilitate RA-induced NB4 cell maturation.
Eect of RA and cAMP on the expression of Stat1, p48 and IRF-1 in NB4 and RA-primed NB4-R1 cells.
To investigate whether RA and cAMP act synergistically on Stat1 and IRF expressions, NB4 cells were treated for 48 h with RA, cAMP or their combination and their cell extracts were analysed by Western blot for Stat1, p48 and IRF-1 protein levels. cAMP alone caused a low increase in the expression of Stat1 protein and did not alter the level of p48 and IRF-1. However, when combined with RA, it has a synergistic eect on the upregulation of Stat1, p48 and IRF-1 expression (Figure 8a ). The cAMP-dependent component of the synergism between RA and cAMP is due to an activation of the PKA system, since the eect was completely blocked by a speci®c inhibitor of cyclic nucleotide-activated kinase, the Rp-8Cl-cAMP (data not shown). Supernatants from NB4 cells treated for 48 h with RA, cAMP and their combination were tested for their ability to induce antiviral state in F2000 cells challenged with VSV, the antiviral titer values were 8, 54 and 96 units/ml respectively. Thus, synergistic eect by RA and cAMP combination on Stat1, p48 and IRF-1 expression is accompanied by a higher IFN synthesis. In both NB4-R1 and RA-primed NB4-R1 cells, cAMP slightly increased the expression of Stat1, did not alter that of p48 (Figure 8b ) and did not induce IFN synthesis indicating the absence of synergistic action on the expression of these factors. In contrast, cAMP induced a higher level of IRF-1 in RA-primed compared to NB4-R1 cells (Figure 8b ). Synergistic maturation of NB4 and RA-primed NB4-R1 cells by cAMP and RA combination is apparently accompanied by distinct regulation pathways.
Discussion
In this report, we focus on the eect of RA in parental and resistant NB4 cells on the IFN system i.e. Stat1, IRF-1, IRF-3 and p48 expressions in order to understand the role of these factors in RA-induced inhibition of cell growth and dierentiation and in RAinduced IFN synthesis. Clarifying pathways deregulated in the NB4-R1 and NB4-R2 cells could help elucidate some of the resistance mechanisms.
Here, we show that 1 mM RA induces in NB4, but not in NB4-R1 and NB4-R2 cells the secretion of 256 units of IFN, characterized as type a. By the use of antibodies neutralizing reactions, we show that this RA-induced IFN could play a role in inhibition of NB4 cell proliferation and not in their maturation.
We and others have also shown that RA impinges with the IFN system by upregulating the expression of the crucial transcription factors STAT (Stat1 and Stat2) and IRF (IRF-1 and p48) (Gianni et al., 1997; Kolla et al., 1996; Matikainen et al., 1996 Matikainen et al., , 1997 Pelicano and Chelbi-Alix, 1998; Pelicano et al., 1997) . By upregulating Stat1 expression in IFN resistant breast tumour cells, RA is able to restore IFN sensitivity (Kolla et al., 1996) . It has been recently shown that RA increases the level of Stat1 and Stat2 in various cell lines (Gianni et al., 1997; Kolla et al., 1996; Matikainen et al., 1997; Pelicano and Chelbi-Alix, 1998; Pelicano et al., 1997) . Thus, increase of STAT expression by RA may be a crucial step in the enhancement by RA of biological responsiveness to IFNs. Moreover, Stat1 promoter directly responds to RA treatment (Weihua et al., 1997) . Recent studies have shown that Stat1 mRNA is induced in the presence of cycloheximide by IFN of type I and II , suggesting that in addition to the RARE, ISRE and GAS could also be present in this promoter. The human Stat2 gene promoter has a functional ISRE site (Yan et al., 1995) which could be Figure 8 Eect of RA and cAMP on the expression of Stat1, p48 and IRF-1 in NB4 and RA-primed NB4-R1 cells. NB4 cells were untreated (C) or treated for 48 h with 1 mM RA alone, 100 mM 8-CPT-cAMP alone or RA and cAMP combination (a). For (b), the samples were as follows: untreated NB4-R1 cells (C), RA-primed NB4 cells (1 mM RA for 3 days), NB4-R1 cells treated for 48 h with 100 mM 8-CPT-cAMP alone, RA-primed NB4 cells (1 mM RA for 3 days) then triggered for 48 h incubation with 100 mM 8-CPT-cAMP in the presence of RA. At the end of incubation, cell extracts were analysed by Western blot for Stat1, p48, IRF-1 and actin protein levels responsive to IRF-1 or IFNa. The expression of Stat1 and Stat2 were highly induced by RA in NB4 cells whereas their induction at protein and mRNA levels were completely blocked in both resistant cells (this report and data not shown).
In NB4, NB4-R1 and NB4-R2 cells, IFN (a or g) increased the expression of PKR, Sp100 and Stat1, inhibited their growth and induced Stat1 activation (see above and data not shown) suggesting that the IFN receptors are functional in the three cell lines. In NB4 cells, RA and IFN act cooperatively in increasing dierent IFN-stimulated genes and enhancing diverse biological activities such as dierentiation, inhibition of cell or virus growth. In contrast, in NB4-R1 and NB4-R2 cells, RA was unable to enhance IFN-induced biological activities, likely due to the absence of IFN synthesis and increase of Stat1 expression. Interestingly, RA altered dierently the expression of two IRF factors, p48 and IRF-1. Upon RA treatment, p48 expression increase was not observed in NB4-R1 and NB4-R2 cells. In contrast, IRF-1 mRNA and protein expressions were induced by RA in both resistant cells. Whether p48, like IRF-1 (Matikainen et al., 1996; Pelicano et al., 1997) , is transcriptionally regulated by RA remains to be studied. Thus, our results show that RA induced IRF-1 expression in the two resistant cell lines without any inhibition of their cell growth. However, we cannot exclude that in parental cells, RA induces IRF-1 activation which could be impaired in the resistant cells. Taken together, these results suggest that RA-induced Stat1 expression and IFNa secretion may be one of the molecular mechanisms mediating growth inhibition by RA.
RA and cAMP which show synergistic activity in inducing maturation of NB4 cells and maturation of the RA`primed' NB4-R1 resistant cells (Ruchaud et al., 1994) , distinctly modulate Stat1, p48 and IRF-1 expressions (this paper). In NB4 cells, RA and cAMP act synergistically to induce IFN synthesis and the expression of Stat1, IRF-1 and p48. In contrast, upon cAMP treatment, only IRF-1 level was enhanced in RA`primed' NB4-R1 compared to NB4-R1 cells. Thus, dierent target genes are regulated by RA and cAMP combination in synergistic induction of NB4 and NB4-R1 cells maturation.
Various studies have shown that four members (IRF-1, IRF-2, p48 and IRF-3) of the growing IRF family have been implicated to play a role in regulating, through ISRE, the ISG as well as type I IFN (reviewed in Nguyen et al., 1997) . IFN gene induction is activated by overexpression of IRF-1, whereas the IRF-2 factor suppresses IFN expression. The DNA binding component of ISGF3, p48, also binds to virus-inducible element in the IFNa/b genes suggesting that ISGF3 may participate directly in the activation of IFNa/b promoters (Harada et al., 1996) . Recently, it has been shown that viral infection induces IRF3 phosphorylation leading to its translocation from the cytoplasm to the nucleus and activation of ISG and type I IFN .
How RA induces IFN synthesis remains to be elucidated. IRF3 seems not to be implicated in IFN induced by RA as IRF3 was phosphorylated in NB4 cells after Sendai virus infection and not after RA treatment (this report). Also, RA did not increase IRF3 expression. It is unlikely that ISGF3 is formed after RA treatment and responsible for IFN induction, because RA is not able to stimulate the tyrosine phosphorylation of Stat1 (this paper and Matikainen et al., 1996) . In addition to the GAS site (Pine et al., 1994) , a putative NF-kB site has been found in the IRF-1 gene promoter (Sims et al., 1993) . IFNg and TNF synergistically increase IRF-1 gene expression through the activation of Stat1 and NF-kB transcription factors respectively (Ohmori et al., 1997; Pine, 1997) . In NB4 cells, RA alone did not induce any detectable Stat1 (Matikainen et al., 1996 and this report) or NF-kB (Matikainen et al., 1996) DNA binding activities, suggesting that these factors are not implicated in RA-induced IRF-1 gene expression. In this report, comparison of kinetics studies clearly shows that RA-induced IRF-1 expression in NB-4 cells precedes IFNa secretion. However, in resistant cells, RA is still able to induce IRF-1 mRNA and protein expression in the absence of detectable IFN secretion. Thus, in this system, increase of IRF-1 expression by RA is not sucient to induce IFN synthesis.
It has been shown that HL-60 myeloid cells are rendered unresponsive to the dierentiating activity of RA by a mutation in the RARa, gene (Robertson et al., 1992) . The resistance might be overcome by transfecting the wild type RARa cDNA (Collins et al., 1990) . RA treatment of NB4 resistant cells overexpressing RARa will reveal whether it could restore IFN synthesis, Stat1 and p48 increase and cell dierentiation.
In conclusion, by demonstrating that RA is unable to induce IFN synthesis and to increase Stat1 and p48 expressions in NB4-R1 and NB4-R2, our results identify some defects in gene expression linked to RA-resistance in APL cells and suggest that in NB4 cells, RA-induced IFNa secretion and Stat1 expression may be one of the mechanisms mediating growth inhibition by RA.
Materials and methods

Reagents
All-trans retinoic acid (RA), 8-(4-chlorophenylthio)adenosine cyclic 3',5'-phosphate (8-CPT-cAMP) and nitroblue tetrazolium (NBT) were purchased from Sigma-Aldrich (St Louis, MO, USA). 10 72 M RA stock solution was prepared in DMSO and stored at 7208C in the dark. A stock solution (10 72 M) of 8-CPT-cAMP was made in RPMI-1640 medium and stored 7208C. Rp-8-chloroadenosine cyclic 3',5'-phosphorothioate (Rp-8Cl-cAMP) was from Alexis corporation, San Diego, USA). DMEM, RPMI and foetal calf serum (FCS) were supplied by Gibco (France). Speci®c antibodies anti-Stat1a, anti-IRF-2, anti-p48 and anti-IRF-1 were all from Santa Cruz Biotechnology (CA, USA), anti-PhosphoStat1 from Upstate Biotechnology and anti-PKR antibodies from Ribogene, Inc.
Cell culture conditions
The NB4 APL and the NB4-derived cell lines (NB4-R1 and NB4-R2) were kindly provided by M Lanotte (Duprez et al., 1992; Lanotte et al., 1991; Ruchaud et al., 1994) . These cell lines were grown in RPMI-1640 supplemented with 10% FCS under the same conditions as previously reported for the isolation and maintenance of the NB4 cell line. Bovine MDBK and human F2000 cells were grown in DMEM supplemented with 10% heat inactivated foetal calf serum.
Determination of IFN titers
All cells (1.5610 5 /ml) were treated with 1 mM RA. At the indicated times in ®gures, IFN titer values were determined on a portion of the culture medium on bovine MDBK cells (sensitive to human IFNa only) and human ®broblasts cells F2000 (sensitive to human IFNs a, b, and g) challenged with vesicular stomatitis virus (VSV). IFN titers, determined as the amounts of IFN required to produce 50% inhibition of the cytopathic eect, were expressed in relation to the human IFNa reference (G-023-902-527, National Institute of Health).
Human IFNs and anti-human IFN antibodies
Recombinant IFNa2 (10 8 international u/mg) was from Schering (USA). Anti-human IFNa, IFNb and IFNg antibodies, having 4610 4 , 10 4 and 4610 4 neutralizing units/ ml respectively, were a gift from J Wietzerbin. The supernatants from RA-treated NB4 cells, saved daily, were incubated 30 min at 378C without or with anti-IFNa, -IFNb or-IFNg antibodies (in each case in amounts sucient to neutralize 1000 units/ml) then they were added to untreated F2000 cells (4610 5 ). After 18 h incubation at 378C, cells were infected with VSV at a MOI of 0.1 and IFN titers were determined as described.
Characterization of cell dierentiation and analysis of cyto-dierentiation markers
Dierentiation of NB4, NB4-R1 and NB4-R2 cells was also assessed by the ability of the cells to produce superoxide. This was measured by the degree of reduction of nitrobluetetrazolium (NBT, Sigma-Aldrich) achieved by the cells over a 30 min period at 378C, in the presence of phorbol myristate acetate (PMA, Sigma-Aldrich) (Miller et al., 1995) .
Western-blot analysis
Untreated and treated cells were washed in PBS, centrifuged and the pellet was boiled for 10 min in 125 mM Tris pH 7, 1% SDS, 10% glycerol, 0.75 mM PMSF. For IRF-3 analysis, cell extracts were prepared as described previously . Thirty mg of protein was analysed on a 10% SDS ± PAGE gel and transferred to nitrocellulose by semi-dry blotting. Membranes were blocked with 10% skimmed milk in TBS-0.1% Tween for 2 h and incubated overnight with the following speci®c antibodies anti-Stat1a (mouse, 1/1500), anti-IRF-2 (rabbit, 1/1500), anti-p48 (rabbit, 1/1500), anti-IRF-1 (rabbit, 1/1500), anti-PKR (mouse, 1/5000) or antiPhospho-Stat1 (rabbit, 1/1000). These initial incubations were followed by incubation with anti-rabbit IgG or anti-mouse IgG horse radish peroxidase-conjugated antibodies (Biosys). Antibody complexes were detected by chemiluminescence using the ECL kit (Amersham, Aylesbury, UK). To estimate the apparent molecular mass of polypeptides, kaleidoscope prestained MW-standards from BioRad were used (BioRad laboratories, Richmond, CA, USA).
Northern blot analysis
All experiments were performed during the exponential growth phase of the cells. Cells were treated with various stimuli, harvested at the times indicated and total RNA was extracted with a Bioprobe Systems RNA extraction Kit Standard. Samples containing equal amounts of total RNA (20 mg) were size-fractionated on 1% formaldehyde-agarose gels and transferred to nitrocellulose membranes (Scheicher and Schuell). Radiolabelled IRF-1 (Maruyama et al., 1989) , Stat1 and GADPH cDNA probes were prepared by random priming.
Electrophoretic mobility shift assays
Cells were treated as described in legends, harvested and whole cell nuclear extracts prepared (Gupta et al., 1996) . Brie¯y, 3610 7 cells were washed with cold PBS and lysed in 800 ml of cold freshly prepared lysis buer (0.5% NP-40, 50 mM Tris pH 8.0, 10% glycerol, 0.1 mM EDTA, 200 mM NaCl, 1 mM DTT) completed with proteases inhibitors (Complete TM protease inhibitor cocktail, Boehringer Mannheim). Five mg of proteins were examined by Electrophoretic Mobility Shift Assays (EMSA) as described elsewhere (Pine et al., 1994 ) with a GAS probe (labelled by Klenow-®ll in) from the IRF-1 gene (ggggatcGATTTCCCCGAAAT, Cybergene). 
